Elan complete royalty rights deal

Irish pharmaceutical firm Elan has completed the acquisition of the royalty rights of three drugs from Pharma Operating.

Elan complete royalty rights deal

Irish pharmaceutical firm Elan has completed the acquisition of the royalty rights of three drugs from Pharma Operating.

Elan said this morning that it has completed the purchase of the rights in respect of Zonegran, Frova and Zanaflex for $99.6m (€83.75m).

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited